+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Review article: supra-oesophageal manifestations of gastro-oesophageal reflux disease and the role of night-time gastro-oesophageal reflux



Review article: supra-oesophageal manifestations of gastro-oesophageal reflux disease and the role of night-time gastro-oesophageal reflux



Alimentary Pharmacology and Therapeutics 20(Suppl. 9): 26-38



Gastro-oesophageal reflux disease (GERD) has been associated with a variety of supra-oesophageal symptoms, including asthma, laryngitis, hoarseness, chronic cough, frequent throat clearing and globus pharyngeus. GERD may be overlooked as the underlying mechanism for these symptoms because typical GERD symptoms may be absent, despite abnormal oesophageal acid exposure. Two basic mechanisms linking GERD with laryngeal symptoms have been proposed: direct contact of gastric acid with the upper airway, in some cases due to micro-aspiration, and a vagovagal reflex triggered by acidification of the distal portion of the oesophagus. Gastro-oesophageal reflux (GER) during sleep is believed to be an important mechanism for the development of supra-oesophageal complications of GERD, such as asthma and idiopathic pulmonary fibrosis (IPF). Several physiological changes during sleep, including prolonged oesophageal acid contact time, decreased upper oesophageal sphincter pressure, increased gastric acid secretion, decreased salivation, decreased swallowing and a decrease in conscious perception of acid, render an individual more susceptible to reflux-induced injury. Supra-oesophageal symptoms often improve in response to aggressive acid-suppressive therapy. However, many unanswered questions remain regarding the appropriate approach to diagnosis and treatment of patients with GERD-related supra-oesophageal symptoms. In this article we review the relationship between supra-oesophageal symptoms and GERD and, where possible, highlight the evidence supporting the role of night-time reflux as a contributing factor to these symptoms.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 012517787

Download citation: RISBibTeXText

PMID: 15527462

DOI: 10.1111/j.1365-2036.2004.02253.x


Related references

Review article: supra-oesophageal manifestations of gastro-oesophageal reflux disease. Alimentary Pharmacology and Therapeutics 19(Suppl. 1): 43-48, 2004

Review article: the pathophysiology of gastro-oesophageal reflux disease - oesophageal manifestations. Alimentary Pharmacology and Therapeutics 20(Suppl. 9): 14-25, 2004

Review article: a conceptual model for the relationship of nocturnal acidity and extra-oesophageal manifestations of gastro-oesophageal reflux disease - where are we now?. Alimentary Pharmacology and Therapeutics Symposium Series 3(1): 31-37, 2007

Effect of atropine on gastro-oesophageal reflux and transient lower oesophageal sphincter relaxations in patients with gastro-oesophageal reflux disease. Gut 43(1): 12-16, 1998

Supra-oesophageal manifestations of gastro-oesophageal reflux disease. Drugs 65(Suppl. 1): 67-73, 2005

Supra-oesophageal manifestations of gastro-oesophageal reflux disease. European Journal of Gastroenterology and Hepatology 15(12): 1339-1350, 2003

Supra-oesophageal manifestations of gastro-oesophageal reflux disease. Alimentary Pharmacology and Therapeutics 19(Suppl. S1): 43-48, 2004

Symptomatic gastro-oesophageal reflux, abnormal oesophageal acid exposure, and mucosal acid sensitivity are three separate, though related, aspects of gastro-oesophageal reflux disease. Gut 32(2): 128-132, 1991

Review article: the nature of oesophageal injury in gastro-oesophageal reflux disease. Alimentary Pharmacology and Therapeutics 24(Suppl. 2): 17-26, 2006

Review article: intragastric and oesophageal pH monitoring in patients with gastro-oesophageal reflux disease. Alimentary Pharmacology and Therapeutics 23(Suppl. 1): 3-11, 2006

Review article: oesophageal complications and consequences of persistent gastro-oesophageal reflux disease. Alimentary Pharmacology and Therapeutics 20(Suppl. 9): 47-56, 2004

Review article: the clinical relevance of transient lower oesophageal sphincter relaxations in gastro-oesophageal reflux disease. Alimentary Pharmacology and Therapeutics 33(6): 650-661, 2011

Review article: Transient lower oesophageal sphincter relaxations: A pharmacological target for gastro-oesophageal reflux disease?. Alimentary Pharmacology and Therapeutics 16(1): 17-26, 2002

Systematic review and meta-analysis of randomised controlled trials of gastro-oesophageal reflux interventions for chronic cough associated with gastro-oesophageal reflux. BMJ 332(7532): 11-17, 2005

The De Carvalho test in the demonstration of gastro-oesophageal reflux, of a "silent" hiatus hernia and of reflux oesophagitis, with a review of the factors influencing the gastro-oesophageal junction. Australasian Radiology 17(4): 375-393, 1973